[Extramedullary relapse of acute myeloid leukemia with pericardial effusion after allogeneic hematopoietic stem cell transplantation].

Authors

Yurie Saitou, Hayato Matsumoto, Takuro Shimbo, Shin Matsuda

Published in

[Rinsho ketsueki] The Japanese journal of clinical hematology. Volume 66. Issue 3. Pages 170-176.

Abstract

A 62-year-old man presented with anemia and neutropenia, and was diagnosed with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC). His disease was refractory to treatment, but went into remission after a third regimen, venetoclax plus azacitidine (Ven+Aza). However, the disease relapsed during treatment for an infection, and he underwent allogeneic peripheral blood stem cell transplant while not in remission. He did not achieve remission after transplantation, but treatment with azacitidine and early discontinuation of immunosuppressants led to remission. However, relapse occurred on day250 in the form of pericardial effusion. After drainage, Ven+Aza therapy was started again, and the pericardial effusion disappeared rapidly. The patient has been continuing the same treatment, and has remained in remission for more than 15 months. Isolated extramedullary relapse caused by pericardial effusion is rare, and this case illustrates that Ven+Aza therapy may be effective.

PMID:
40175139
Bibliographic data and abstract were imported from PubMed on 03 Apr 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.